APP下载

甲氨蝶呤和阿维A治疗银屑病效果比较的Meta分析

2016-12-27罗丽敏李军刘劲松

中国医药导报 2016年29期
关键词:Meta分析

罗丽敏 李军 刘劲松

[摘要] 目的 系统评价甲氨蝶呤和阿维A治疗银屑病的有效性和安全性。 方法 计算机检索Medline、Cochrane图书馆、EMbase、维普、中国期刊和万方数字化期刊全文数据库,纳入甲氨蝶呤对比阿维A治疗银屑病的随机对照试验,采用RevMan 5.1软件进行Meta分析。 结果 共纳入12篇随机对照试验,包括共877例患者。Meta分析显示:甲氨蝶呤组6周的疗效与阿维A组比较,差异无统计学意义(OR = 1.21,95%CI:0.51~2.87,P = 0.66);治疗8周时,甲氨蝶呤组疗效低于阿维A组(OR = 0.17,95%CI:0.04~0.72,P = 0.02);治疗12周时,甲氨蝶呤组疗效明显高于阿维A组(OR = 3.20,95%CI:1.93~5.31,P < 0.000 01)。甲氨蝶呤组不良反应明显低于阿维A组(OR = 0.14,95%CI:0.04~0.52,P = 0.004)。甲氨蝶呤组与阿维A组治疗银屑病的复发率比较差异无统计学意义(OR = 1.23,95%CI:0.17~8.98,P = 0.84)。 结论 甲氨蝶呤长期治疗银屑病的效果优于阿维A,甲氨蝶呤不良反应明显低于阿维A,二者复发率差异不明显。上述结论尚需要更多高质量的随机对照试验验证。

[关键词] 甲氨蝶呤;阿维A;银屑病;Meta分析;随机对照试验

[中图分类号] R758.63 [文献标识码] A [文章编号] 1673-7210(2016)10(b)-0136-04

[Abstract] Objective To evaluate the efficacy and security of Methotrexate and Acitretin for psoriasis systematically. Methods The randomized controlled trials (RCTs) of Methotrexate and Acitretin for psoriasis from the Medline, the Cochrane library, EMbase, VIP, CNKI and Wanfang data were collected. The Cochrane Collaboration RevMan 5.1 software was used for Meta analysis. Results There were 12 randomized controlled trials involving 877 patients. The Meta analysis showed that the efficacies of Methotrexate and Acitretin at the end of the 6th week had no statistic difference respectively (OR = 1.21, 95%CI: 0.51-2.87, P = 0.66); but for the 8th week, the Methotrexate group was slightly lower than the Acitretin group (OR = 0.17, 95%CI: 0.04-0.72, P = 0.02); for the 12th week, the efficacy of the Methotrexate group was obviously higher than that of the Acitretin group (OR = 3.20, 95%CI: 1.93-5.31, P < 0.000 01). It also revealed that the incidence of adverse effects of the Methotrexate group was obviously lower than that of the Acitretin group (OR = 0.14, 95%CI: 0.04-0.52, P = 0.004), but there was no difference of the recurrence incidence between the two groups (OR = 1.23, 95%CI: 0.17-8.98, P = 0.84). Conclusion Methotrexate is more efficient than Acitretin in the long term therapy, the incidence of adverse effects of Methotrexate is obviously lower than Acitretin, but there is no difference between the recurrence incidence of Methotrexate and Acitretin. More high quality RCTs are required to verify these conclusions.

[Key words] Methotrexate; Acitretin; Psoriasis; Meta Analysis; Randomized controlled trials

银屑病是皮肤科常见的红斑鳞屑性疾病,发病率较高,其病因及发病机制尚不清楚,病情常反复发作,严重者影响患者的生理及心理健康。甲氨蝶呤(Methotrexate,MTX)和阿维A作为治疗银屑病的常规药物,MTX长期用药可导致肝纤维化、骨髓抑制等不良反应,且停药后病情易反复,而阿维A育龄妇女服用后可导致胎儿畸形,长期应用则可引起皮肤黏膜干燥、脱屑、肝脏损害等不良反应而使它们的应用受到进一步的限制[1]。本研究拟对MTX和阿维A治疗银屑病的随机对照试验(randomized controlled trial,RCT)进行系统评价,以期为临床治疗提供更多参考依据。

1 资料与方法

1.1 纳入标准

纳入研究为RCT,无论是否隐藏或采用盲法,研究对象是临床诊断为银屑病的患者,组间均衡性较好,具有可比性。干预措施:MTX组患者给予MTX治疗,阿维A组患者给予阿维A胶囊口服。结局指标:采用银屑病皮损面积和严重性指数评分判定疗效,皮损消退≥90%为痊愈;……

登录APP查看全文

猜你喜欢

Meta分析
雷公藤多苷治疗糖尿病肾病的疗效及安全性评价
胱硫醚β—合成酶G919A基因多态性与原发性高血压关系的meta分析
毫针针刺治疗骨关节炎疗效的Meta分析
高压氧治疗血管性痴呆随机对照试验的Meta分析
持续气道正压通气对合并阻塞性睡眠呼吸暂停的难治性高血压疗效的Meta分析
腹腔镜评估晚期卵巢癌患者能否行满意的肿瘤细胞减灭术的Meta分析
结直肠进展腺瘤发生率的Meta分析
血小板与冷沉淀联合输注在大出血临床治疗中应用的Meta分析
细辛脑注射液治疗慢性阻塞性肺疾病急性加重期疗效的Meta分析
中药熏洗治疗类风湿关节炎疗效的Meta分析